Summary
For Year 2026-27, Ipca Laboratories reports the following shareholding: Total Promoters at 44.72%, Mutual Fund at 31.24%, Insurance at 5.34%, Foreign Institutional Investors at 10.63%, Domestic Institutional Investors at 0.87%, and Retail at 7.2%. This breakdown provides a quick snapshot of ownership distribution for Ipca Laboratories in 2026-27.
Ipca Laboratories FAQs
As of 04-2026, the promoter shareholding in Ipca Laboratories stands at 44.72% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Ipca Laboratories is 10.63% and 0.87% respectively.
The retail shareholding of the Ipca Laboratories is 7.2%.
Changes in shareholding patterns of Ipca Laboratories can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Ipca Laboratories are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
Ipca Laboratories Associated Pages
